Publication | Closed Access
Design, synthesis and molecular docking study of new pyrimidine-based hydrazones with selective anti-proliferative activity against MCF-7 and MDA-MB-231 human breast cancer cell lines
30
Citations
39
References
2023
Year
Medicinal ChemistryNew Pyrimidine-based HydrazonesSelective Anti-proliferative ActivityMedicinePharmacologyTumor TargetingAnti-cancer AgentMolecular DockingRadiation OncologyMolecular Docking StudyDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1